Monopar Therapeutics Inc. · NASDAQ:MNPR
Saturn V Capital Management LP's stake in Monopar Therapeutics Inc. fell to 4.70% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 12, 2026
Saturn V Capital Management LP's stake in Monopar Therapeutics Inc. fell to 4.70%, 313,384 shares, as a passive investor on Jun 30, 2026. Filed Aug 12, 2026 (Schedule 13G/A).
- Stake
- 4.70%
- Shares
- 313,384
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Saturn V Capital Management LP | 4.70% | 313,384 |
| Xiaoying Tian | 4.70% | 313,384 |
Source
Related
- Monopar Therapeutics Inc.
- Saturn V Capital Management LP
- Monopar Therapeutics Inc. shareholders
- Schedule 13G · Saturn V Capital Management LP · May 15, 2026
- Form 4 · Robinson Chandler · Oct 20, 2026
- Form 4 · Starr Christopher M · Oct 5, 2026
- Form 4 · Cittadine Andrew · Oct 2, 2026
- Form 4 · Vu Quan Anh · Oct 2, 2026
- Form 4 · Robinson Chandler · Oct 2, 2026